PEPPOLONI, Samuele
 Distribuzione geografica
Continente #
EU - Europa 21.633
NA - Nord America 14.781
AS - Asia 7.766
SA - Sud America 905
Continente sconosciuto - Info sul continente non disponibili 388
AF - Africa 159
OC - Oceania 19
Totale 45.651
Nazione #
IT - Italia 15.738
US - Stati Uniti d'America 14.471
SG - Singapore 2.758
GB - Regno Unito 2.199
CN - Cina 2.008
HK - Hong Kong 928
DE - Germania 744
FR - Francia 693
VN - Vietnam 670
BR - Brasile 661
SE - Svezia 654
UA - Ucraina 346
BD - Bangladesh 282
FI - Finlandia 272
RU - Federazione Russa 272
TR - Turchia 243
KR - Corea 209
IN - India 179
MX - Messico 133
BG - Bulgaria 122
CA - Canada 115
NL - Olanda 98
AR - Argentina 91
ID - Indonesia 81
AT - Austria 80
IQ - Iraq 67
PL - Polonia 62
BE - Belgio 51
JP - Giappone 51
RO - Romania 49
ZA - Sudafrica 47
ES - Italia 40
IE - Irlanda 40
PK - Pakistan 36
AE - Emirati Arabi Uniti 34
CH - Svizzera 33
MA - Marocco 32
CO - Colombia 29
CL - Cile 27
EC - Ecuador 25
VE - Venezuela 25
UZ - Uzbekistan 23
PH - Filippine 22
MY - Malesia 21
PT - Portogallo 21
LT - Lituania 19
AU - Australia 17
CZ - Repubblica Ceca 17
IR - Iran 17
KE - Kenya 17
PY - Paraguay 17
TH - Thailandia 16
JO - Giordania 15
CR - Costa Rica 13
EG - Egitto 12
IL - Israele 12
DK - Danimarca 11
NP - Nepal 11
PE - Perù 11
SA - Arabia Saudita 11
TN - Tunisia 11
DZ - Algeria 10
TW - Taiwan 10
KG - Kirghizistan 9
UY - Uruguay 9
AL - Albania 8
HN - Honduras 8
AZ - Azerbaigian 7
DO - Repubblica Dominicana 7
EU - Europa 7
NO - Norvegia 7
PA - Panama 7
BO - Bolivia 6
EE - Estonia 6
GR - Grecia 6
KH - Cambogia 6
QA - Qatar 6
RS - Serbia 6
BY - Bielorussia 5
GE - Georgia 5
MT - Malta 5
SN - Senegal 5
SV - El Salvador 5
AM - Armenia 4
ET - Etiopia 4
GT - Guatemala 4
HR - Croazia 4
JM - Giamaica 4
SM - San Marino 4
BH - Bahrain 3
BS - Bahamas 3
CY - Cipro 3
KW - Kuwait 3
KZ - Kazakistan 3
LB - Libano 3
LU - Lussemburgo 3
LV - Lettonia 3
MK - Macedonia 3
SI - Slovenia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
Totale 45.215
Città #
Singapore 2.001
Southend 1.564
Santa Clara 1.465
Ashburn 1.291
Hong Kong 918
Fairfield 855
Chandler 782
Milan 710
San Jose 681
Woodbridge 647
Hefei 631
Rome 603
Jacksonville 601
Houston 513
Council Bluffs 475
Bologna 454
Dearborn 446
Ann Arbor 444
Beijing 398
Wilmington 349
Nyköping 335
Seattle 321
Los Angeles 300
Chicago 292
Torino 290
London 281
Florence 235
Modena 232
Cambridge 229
New York 217
Ho Chi Minh City 194
Seoul 193
The Dalles 162
Helsinki 157
Hanoi 152
Catania 150
Dallas 133
Genova 125
Verona 119
Padova 118
Princeton 118
Sofia 117
Izmir 115
Salt Lake City 110
Castelnuovo Rangone 105
Bremen 103
Eugene 102
Moscow 101
Venezia 101
Lauterbourg 96
Napoli 94
Turin 94
Des Moines 93
San Diego 92
Munich 89
Buffalo 83
Mexico City 83
Shanghai 83
Pisa 81
Palermo 78
Nuremberg 77
Reggio Nell'emilia 77
Redwood City 76
São Paulo 72
Bari 71
Naples 69
Trento 66
Orem 65
Columbus 61
Tampa 59
Elk Grove Village 58
Trieste 56
Boardman 51
Parma 51
Bolzano 50
Piemonte 50
Jakarta 49
Falls Church 47
Genoa 47
Da Nang 46
Udine 46
Monza 45
Oggiono 45
Tokyo 45
Chennai 43
Norwalk 43
Vienna 43
Frankfurt am Main 41
Messina 40
Atlanta 39
Dublin 37
Nanjing 35
Pavia 35
Phoenix 35
Brussels 34
Reggio Emilia 33
Rio Saliceto 33
Cagliari 32
Montreal 32
Mountain View 32
Totale 23.967
Nome #
RICERCA DI MARCATORI PER LA DIAGNOSI DI INFEZIONE FUNGINA INVASIVAE (IFI) MEDIANTE APPROCCIO DIAGNOSTICO COMBINATO 15.276
Ruolo della proteina pneumococcica di superficie PspC nel l’interazione in vitro di Streptococcus pneumoniae con le cellule microgliali 474
Yessotoxin inhibits phagocytic activity of macrophages. 459
The encapsulated strain TIGR4 of Streptococcus pneumoniae is phagocytosed but is resistant to intracellular killing by mouse microglia 446
Pomegranate extract affects fungal biofilm production: consumption of phenolic compounds and alteration of fungal autoinducers release 444
Adaptive response of microglial cells to in vitro infection by Candida albicans isolates with different genomic backgrounds 441
Longitudinal Survey of Fungi in the Human Gut: ITS Profiling, Phenotyping, and Colonization 425
A protein microarray immunoassay for the serological evaluation of the antibody response in vertically transmitted infections 422
EFFETTI DELLA TOSSINA DI ORIGINE ALGALE YESSOTOSSINA (YTX) SULLA ATTIVITA’ DEL MACROFAGO 414
RUOLO BIOLOGICO DI DUE RECETTORI TOLL-SIMILI, TLR2 E TLR4, NELLA RISPOSTA MACROFAGICA A CANDIDA ALBICANS 405
The synthetic killer peptide KP impairs Candida albicans biofilm in vitro 398
Genomic and phenotypic variation in morphogenetic networks of two Candida albicans isolates subtends their different pathogenic potential 396
La proteina di superficie PspC di pneumococco conferisce resistenza al killing in vitro di Streptococcus pneumoniae da parte di cellule microgliali in maniera indipendente dal complemento 395
Identification and characterization of an aspartyl protease from Cryptococcus neoformans 388
A synthetic killer peptide impairs Candida albicans biofilm formation and persistence in vitro 376
Discovery of novel Streptococcus pneumoniae antigens by screening a whole-genome λ-display library 370
Real-time monitoring of Pseudomonas aeruginosa biofilm formation on endotracheal tubes in vitro 364
Detection of follicular fluid and serum antibodies by protein microarrays in women undergoing in vitro fertilization treatment. 356
NF-kB activation and p38 phosphorilation in microglial cells infected with Leptospira or exposed to partially purified leptospiral lipoproteins 351
An antibody reactivity-based assay for diagnosis of invasive candidiasis using protein array 350
The human immunodeficiency virus (HIV) protease inhibitor indinavir directly affects the opportunistic fungal pathogen Cryptococcus neoformans 349
Compounds released from Lactobacillus (L.) acidophilus, L. plantarum, L. rhamnosus and L. reuteri inhibit Candida parapsilosis pathogenic potential after infection of vaginal epithelial cells in vitro. 348
Role of the (Mn)superoxide dismutase of Enterococcus faecalis in the in vitro interaction with microglia 347
Effects of Cupral® on the formation and persistence of microbial biofilms in vitro 344
The β-Lactamase Inhibitor Boronic Acid Derivative SM23 as a New Anti-Pseudomonas aeruginosa Biofilm 336
Acellular pertussis vaccines composed of genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults. 334
ALTERATA REATTIVITA’ MACROFAGICA IN CORSO DI INFEZIONE MISTA DA VIRUS E FUNGHI:VALUTAZIONI FUNZIONALI, CITOFLUORIMETRICHE E DI ESPRESSIONE GENICA 332
Safety and immunogencity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study 329
Inhibition of Quorum Sensing-dependent biofilm formation and virulence factors in Pseudomonas aeruginosa by the boronic acid SM23 320
Candida albicans survival, growth and biofilm formation are differently affected by mouthwashes: an in vitro study 319
Contribution of different pneumococcal virulence factors to experimental meningitis in mice 313
Antimicrobial and antibiofilm efficacy of a copper/calcium hydroxide-based endodontic paste against Staphylococcus aureus, Pseudomonas aeruginosa and Candida albicans 312
MESSA A PUNTO DI UN SISTEMA INNOVATIVO PER MONITORARE IN TEMPO REALE LA FORMAZIONE DI BIOFILM DI PSEUDOMONAS AERUGINOSA SU TUBI ENDOTRACHEALI 311
Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: safety and immunogenicity in 12- to 24- and 2- to 4-month-old children. 308
Gene expression profiling of monocytes displaying herpes simplex virus 1 induced dysregulation of antifungal defences 301
The β-lactamase Inhibitor Boronic Acid SM23 Inhibits Pseudomonas aeruginosa Biofilm Formation and Virulence Factor Production 299
CANDIDA ALBICANS HYPHAL DEVELOPMENT AND BIOFILM FORMATION/PERSISTENCE ARE DIFFERENTIALLY AFFECTED BY MOUTHWASHES DEPENDING UPON THEIR COMPOSITION. 298
The lack of Pneumococcal surface protein C (PspC) increases the susceptibility of Streptococcus pneumoniae to the killing by microglial cells 294
Diagnostic utility of a microarray based on 11 proteins of Candida albicans for the diagnosis of invasive candidiasis 292
Antibody-dependent macrophage-mediated activity against Helicobacter pylori in the absence of complement 289
RUOLO DELLA SUPEROSSIDO DISMUTASI DI Enterococcus faecalis SULLA REATTIVITA’ DELLA MICROGLIA IN VITRO 277
The quest for a vaccine against Helicobacter pylori: how to move from mouse to man? 274
The Spr1875 protein confers resistance to the microglia-mediated killing of Streptococcus pneumoniae 272
Biological importance of the two Toll-like receptors, TLR2 and TLR4, in macrophage response to infection with Candida albicans 272
Immunogenicity of the B monomer of Escherichia coli heat-Labile Toxin expressed on the surface of the Streptococcus gordonii 271
New strategies for the prevention and treatment of Helicobacter pylori infection 270
Caratterizzazione immunobiologica di nuovi antigeni proteici di Streptococcus pneumoniae selezionati mediante "phage display" 270
Comparative study of a whole-cell pertussis vaccine and a recombinant acellular pertussis vaccine. 264
Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: Safety, immunogenicity, and efficacy 263
A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 response following nasal delivery 263
Acellular pertussis vaccine composed of genetically inactivated pertussis toxin 261
The TIGR4 strain of Streptococcus pneumoniae is phagocytosed but resists intracellular killing by microglia in experimental pneumococcal meningitis 261
Immunogenic Properties of Streptococcus agalactiae FbsA Fragments 256
The Pneumococcal surface protein C (PspC) influences the susceptibility of Streptococcus pneumoniae to microglia 255
Mutants of Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines. 254
COMPARAZIONE DELLA EFFICACIA ANTIBATTERICA DI TETRACLEAN, UN IRRIGANTE ENDODONTICO DI NUOVA GENERAZIONE, CON IPOCLORITO DI SODIO. 254
Attenuation of Pseudomonas aeruginosa Virulence by Pomegranate Peel Extract 252
Immunostimulation by a partially retro-inverso tuftsin analogue containing Thr 1 (NHCO) (R,S) Lys 2 modification 251
Lewis lung carcinoma (3LL) cells treated in vitro with ultraviolet radiation show reduced metastatic ability due to an augmented immunogenicity 250
Host-microbe interaction in Candida mucosal infections: a complex balance (Interazione ospite-microrganismo nelle infezioni mucosali da Candida: un equilibrio complesso) 249
Applicazioni del microarray proteico nella diagnosi diretta per la sierotipizzazione di agenti patogeni 247
The Spr1875 protein of Streptococcus pneumoniae protects the bacterium from microglia-mediated killing 246
The protein “mycoarray”: a novel serological assay for the laboratory diagnosis of primitive endemic mycoses 245
Metabolic, humoral and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G 245
The β-lactamase Inhibitor Boronic Acid SM23 as a new anti-Pseudomonas aeruginosa Biofilm Compound 245
APPLICAZIONE DEI MICROARRAY PROTEICI NELLA DIAGNOSTICA AVANZATA DI PATOLOGIEMICROBICHE E VIRALI 239
The ABC transporter-encoding gene AFR1 affects the resistance of Cryptococcus neoformans to microglia-mediated antifungal activity by delaying phagosomal maturation. 237
Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-N'-nitronitrosoguanidine 237
Safety and immunogenicity in animals of subunit influenza vaccine given intranasally with mutants of Escherichia coli heat-labile enterotoxin (LT) 236
Protective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platform 234
Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (pANCA) Impair Neutrophil Candidacidal Activity and Are Increased in the Cellular Fraction of Vaginal Samples from Women with Vulvovaginal Candidiasis 231
In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets. 229
Lymphokine secretion and cytotoxic activity of human CD4+ T cell clones against Bordetella pertussis 228
Alterazione delle difese monocito-mediate nei confronti di miceti in presenza di virus erpetici 227
Alterazione delle difese monocito-mediate nei confronti di Cryptococcus neoformans in presenza dell’Herpesvirus umano 6 225
Probing the structure-activity relationship of E.coli LT-A by site directed mutagenesis 223
IL MICROARRAY PROTEICO NELL’ANALISI DEI LIQUIDI AMNIOTICI: RICERCA DI MARKER PRECOCI DI INFIAMMAZIONE E/O INFEZIONE CORRELABILI AL PARTO PRETERMINE 222
Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizaztion 217
Physicochemical characterisation of the pertussis vaccine. 217
Immunobiological characterization of genetic products, identified from whole genome lambda-display libraries of Pneumococcus 217
MICROARRAY PROTEICI NELLA DIAGNOSI DIRETTA: SIEROTIPIZZAZIONE DI AGENTI PATOGENI 217
Pneumocystis jirovecii genotyping: experience in a tertiary-care hospital in Northern Italy 217
Interaction of pneumococcal surface structures with microglia 213
Bordetella 207
EDTA and Taurolidine affect Pseudomonas aeruginosa virulence in vitro: impairment of secretory profile and biofilm production onto peritoneal dialysis catheters 205
Protein microarrays on midtrimester amniotic fluids: a novel approach for the diagnosis of early intrauterine inflammation related to preterm delivery 204
A short synthetic peptide fragment of human interleukin-1 beta increases both human and murine natural killer activity 201
RUOLO DI PRODOTTI GENICI IDENTIFICATI MEDIANTE LIBRERIE LAMBDA-DISPLAY DA GENOMA COMPLETO DI PNEUMOCOCCO NELL’INTERAZIONE IN VITRO CON CELLULE MICROGLIALI ED EPITELIALI 200
Inhibitory effects of different lactobacilli on Candida albicans hyphal formation and biofilm development. 199
LA PROTEINA SPR1875 DI STREPTOCOCCUS PNEUMONIAE PROTEGGE IL BATTERIO DAL KILLING DELLA MICROGLIA 197
Properties of the pertussis toxin mutant PT-9K/129G after formaldehyde treatment. 192
Il gene AFR1 di Cryptococcus neoformans codificante per un trasportatore ABC, altera la resistenza del patogeno alla microglia: ritardo nella maturazione dei fagosomi. 191
Risposta differenziale della cellula di microglia ad isolati clinici di Candida albicans con differente genotipo 189
Brucella 188
Plasminogen- and fibronectin-binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cells 188
Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 K 187
Vaginal Clinical Isolates of Candida albicans Differentially Modulate Complosome Activation in Vaginal Epithelial Cells 177
Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with FHA and pertactin in infants and children 177
Protective activity of a protein fragment identified by screening of a phage display genomic library of Streptococcus pneumoniae 170
Ruolo del sierotipo capsulare nella suscettibilità di Streptococcus pneumoniae alla cellula microgliale 169
Totale 43.099
Categoria #
all - tutte 126.992
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.992


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.523 0 0 219 250 168 192 194 209 273 206 437 375
2022/20234.240 398 344 313 375 465 519 210 412 470 152 257 325
2023/20242.432 220 236 218 204 364 203 222 207 96 112 130 220
2024/20255.361 228 167 110 360 1.049 735 404 362 561 203 527 655
2025/202610.420 620 472 686 1.584 2.161 656 1.045 442 934 908 526 386
2026/20271.112 509 549 54 0 0 0 0 0 0 0 0 0
Totale 45.651